POCI vs ZTEK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
POCI exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows impressive top-line revenue growth of 62.80%, this growth is not translating into profitability, as evidenced by a -28.33% profit margin and a catastrophic -73.56% ROE. Liquidity is tight with a Quick Ratio of 0.58, and the company has failed to beat earnings estimates in the last four quarters. The recent short-term price rally appears decoupled from the underlying financial deterioration.
ZTEK exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While the company shows strong top-line revenue growth of 73.10%, this is completely offset by a catastrophic operating margin of -4155.24% and a Price/Sales ratio of 54.78, suggesting extreme overvaluation. The stock is in a persistent bearish trend with a 58.3% decline over the last year and a lack of any meaningful profitability metrics. Overall, the company appears to be a speculative venture with unsustainable operational costs.
Compare Another Pair
Related Comparisons
POCI vs ZTEK: Head-to-Head Comparison
This page compares Precision Optics Corporation, Inc. (POCI) and Zentek Ltd. (ZTEK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.